CURRICULUM VITAE
PERSONAL DETAIL
DR. AHMAD NAZRAN BIN FADZLI |
|||
| Medical Lecturer | |||
| Department of Surgery | |||
| Faculty of Medicine | |||
| +603-79492441 | |||
| +603-79586360 | |||
| ahmadnazran@um.edu.my | |||
| Department of Surgery, Office of The Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia | |||
ResearcherID Link |
http://www.researcherid.com/rid/B-8165-2010 | ||
ACADEMIC QUALIFICATION
(Qualification), (Institution).
- MSurg(UM)(2012), UNIVERSITI MALAYA (UM)
- UNIVERSITY OF LEICESTER, LEICESTER, UK(FARMASI KLINIKAL)
- MBChB(2006), UNIVERSITY OF LEICESTER, LEICESTER, UK
ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).
- Coordinator, Faculty, 16/01/2019 to 31/12/2019
RECENT SELECTED PUBLICATIONS
(Publication).
Article in Academic Journals
2019
- Yii RSL et al., Predictive factors of prostate cancer diagnosis with PSA 4.0e10.0 ng/ml in a multi-ethnic Asian population, Malaysia, Asian Journal of Surgery, https://doi.org/10.1016/j.asjsur.2019.02.014 (ISI-Indexed)
2015
-
NY Yap, R Rajandram, KL Ng, J Pailoor, A Fadzli, GC Gobe. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. Biomed Research International 2015 (2015), Article ID 476508, 22 pages. (ISI-Indexed)
AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).
-
KEYNOTE-676 : Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676), Co-Investigator, 2019 - 2024, Merck Sharp & Dohme (M) Sdn. Bhd
-
Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study, Co-Investigator, 2018 - 2018, International Funding
-
A Phase I V Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT), Co-Investigator, 2016 - 2019, International Funding
-
A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia, Co-Investigator, 2015 - 2020, International Funding
-
SAVE-ONCO: A multinational, randomized, double-
blind, placebo-controlled study to evaluate the
efficacy and safety of AVE5026 in the prevention
of venous throboembolism (VTE) in cancer patients
at high risk for VTE and who are undergoing
chemotherapy, Coordinator, 2008 - 2008, Sanofi-Aventis
PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).
POSTER
- Tubulocystic renal cell carcinoma presenting as spontaneous subcapsular haematoma, 22nd Malaysian Urological Conference, 2013-11-22 to 2013-11-24, Malaysian Urological Association, (National)
- Transrectal Ultrasound Guided Prostate Biopsy Complications - a UMMC experience, 23rd Malaysian Urological Conference, 2014-11-21 to 2014-11-23, Malaysian Urological Association, (National)
- Ultra-Mini Percutaneous Nephrolithotripsy: A UMMC Experience, Malaysian Urology Conference, 2015-11-20 to 2015-11-22, MUC, (National)
- Percutaneous Nephrolithotomy (PCNL) in a case of Horseshoe Kidney, 27th World Congress on Videourology & Clinical Urology, 2016-06-09 to 2016-06-12, Thai Urological Association, (International)
- Efficacy of Oral Chondroitin Sulphate (urosulf) in Reducing Ureteric Stent Related Symptoms, 14th Urological Association of Asia Congress 2016, 2016-07-20 to 2016-07-24, UAA & SUA, (International)
- metastatic RCC to contralateral ureter, Malaysian Urological COnference, 2016-11-24 to 2016-11-27, MUA, (National)
PRESENTER
- hair in urethra post scrotal skin hypospadias repair, Malaysian urological conference, 2017-12-24 to 2017-12-26, MUA, (National)
CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).
- AWANI pagi: Bulan Kesedaran Kesihatan Lelaki Sedunia, (National), 30/11/2019 until 30/11/2019